JP2025502157A5 - - Google Patents

Info

Publication number
JP2025502157A5
JP2025502157A5 JP2024541632A JP2024541632A JP2025502157A5 JP 2025502157 A5 JP2025502157 A5 JP 2025502157A5 JP 2024541632 A JP2024541632 A JP 2024541632A JP 2024541632 A JP2024541632 A JP 2024541632A JP 2025502157 A5 JP2025502157 A5 JP 2025502157A5
Authority
JP
Japan
Prior art keywords
cycles
protein
series
affinity matrix
impurity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025502157A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/010594 external-priority patent/WO2023137062A1/en
Publication of JP2025502157A publication Critical patent/JP2025502157A/ja
Publication of JP2025502157A5 publication Critical patent/JP2025502157A5/ja
Pending legal-status Critical Current

Links

JP2024541632A 2022-01-12 2023-01-11 アフィニティークロマトグラフィーを使用した不純物からのヘテロ二量体タンパク質の分離能を改善する方法 Pending JP2025502157A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263298745P 2022-01-12 2022-01-12
US63/298,745 2022-01-12
US202263430477P 2022-12-06 2022-12-06
US63/430,477 2022-12-06
PCT/US2023/010594 WO2023137062A1 (en) 2022-01-12 2023-01-11 Methods for improving resolution of heterodimeric proteins from impurities using affinity chromatography

Publications (2)

Publication Number Publication Date
JP2025502157A JP2025502157A (ja) 2025-01-24
JP2025502157A5 true JP2025502157A5 (enExample) 2026-01-20

Family

ID=85382626

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541632A Pending JP2025502157A (ja) 2022-01-12 2023-01-11 アフィニティークロマトグラフィーを使用した不純物からのヘテロ二量体タンパク質の分離能を改善する方法

Country Status (10)

Country Link
US (1) US20230242579A1 (enExample)
EP (1) EP4463463A1 (enExample)
JP (1) JP2025502157A (enExample)
KR (1) KR20240132357A (enExample)
AU (1) AU2023207604A1 (enExample)
CA (1) CA3242938A1 (enExample)
IL (1) IL314032A (enExample)
MX (1) MX2024008637A (enExample)
TW (1) TW202337900A (enExample)
WO (1) WO2023137062A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI507525B (zh) 2009-06-26 2015-11-11 Regeneron Pharma 具天然免疫球蛋白形式之易分離的雙專一性抗體
EP3041593B1 (en) * 2013-09-05 2025-01-29 F. Hoffmann-La Roche AG Method of cleaning a chromatography material for its reuse
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3956046A1 (en) * 2019-04-17 2022-02-23 Bristol-Myers Squibb Company Methods for regenerating chromatography resins

Similar Documents

Publication Publication Date Title
JP2020040952A5 (enExample)
US10919930B2 (en) Enhanced purification of antibodies and antibody fragments by apatite chromatography
JP2015503524A5 (enExample)
JP2007532477A5 (enExample)
KR101569783B1 (ko) 항체의 정제 방법
KR101226353B1 (ko) 면역글로불린 정제
US20100069617A1 (en) Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
JP2016538264A (ja) 組換えタンパク質の精製方法
US20110166332A1 (en) Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions
KR20130069515A (ko) 항체의 정제 방법
JP2015512621A5 (enExample)
CN101180317A (zh) 用于纯化抗体的方法
RU2011112989A (ru) Способы очистки однодоменных антигенсвязывающих молекул
EP0368092B1 (en) Ion exchange and separation method
JP2018516229A5 (enExample)
JPH07238034A (ja) Viii:c製剤
RU2014111820A (ru) Способы элиминации вируса
JP2022536659A5 (enExample)
CN107849122A (zh) 用低电导率洗涤缓冲液进行亲和层析纯化
JP2016513643A5 (enExample)
JP2021534398A5 (enExample)
KR20150050386A (ko) 양이온 교환 크로마토그래피를 이용한 항체의 아형 분리 방법
WO2023012828A1 (en) Method to purify an antibody composition using cation exchange chromatography
CN113166200A (zh) 一种提高蛋白a层析法去除聚集体的方法
CA1323567C (en) Method for purification of antibodies